Eclampsia: Study of 35 Cases

Abstract

Eclampsia, is the convulsive disorder of pregnant women in association with pre-Eclampsia. It remains an important cause of maternal deaths in developing countries. Objectives: To find out efficacy of treatment regimen in eclampsia in terms of feto maternal complication (perinatal and maternal mortality and morbidity). Setting Department of obstetric and gynecology, Lady Aitchison’s Hospital, Lahore from 15th July 2003 to 15th June 2004. Patients and Methods: 35 cases of antepartum and intrapartum eclampsia with alive fetus of Gestational age more than 28 weeks were included in study. Results: The results show maternal mortality (primary out comes) in terms of recurrence of seizures and maternal death as (28.6%) and (5.7%) respectively. The maternal morbidity (secondary out comes) in terms of life threatened condition like renal failure (5.7%), Coagulopathy (8.6%), pulmonary edema (14.3%), Pneumonia (14.3%) and cerebrovascular accidents (8.6%).20 (5 7.2%) women have Caesarean section while 15 (42.8%) delivered normally. 24 (68.6%) patients required blood transfusion before delivery and 28 (80%) have haemoglobin less than 10 g/dl on 2nd post- operative day. The perinatal mortality (still birth + neonatal death) was 20% like wise, perinatal morbidity in terms of low apgore score (less than 7 at one minute) is 28.6% and at 5 minute (8.6%). About (14.3%) babies require admission in special unit for less than 7 days. Conclusion: Conclusion are limited to study. Use of MgSO4 as anticonvulsants and early caesarean delivery can reduce the maternal and fetal mortality and morbidity in eclampsia.